Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic in antibody-mediated immunological diseases
2006-003115-49Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in vasculitis, autoantibody mediated diseases, autoimmune kidney disease and 3 more, sponsored by Technical University of Munich. Primary endpoints: Serological antibody course and Organ function parameters. Started Oct 2006; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
vasculitisautoantibody mediated diseasesautoimmune kidney diseaseNot applicable (entry is a general category, not a specific disease)neuroimmunology-related disease
Beyond the preview
Go deeper on 2006-003115-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003115-49.